Should you repeat mismatch repair testing in cases of tumour recurrence? An evaluation of repeat mismatch repair testing by the use of immunohistochemistry in recurrent tumours of the gastrointestinal and gynaecological tracts-Reference-Cited by-同舟云学术

Should you repeat mismatch repair testing in cases of tumour recurrence? An evaluation of repeat mismatch repair testing by the use of immunohistochemistry in recurrent tumours of the gastrointestinal and gynaecological tracts

Published:2020-02-18 Issue:4 Volume:76 Page:521-530
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Aird John J¹²,Steel Michael J¹,Chow Christine³,Ho Julie⁴,Wolber Robert⁵,Gilks C Blake¹²,Hoang Lynn N¹²,Schaeffer David F¹²

Affiliation:

1. Division of Anatomic Pathology Vancouver General Hospital Vancouver BC Canada

2. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver BC Canada

3. Genetic Pathology Evaluation Centre Jack Bell Research Centre Vancouver BC Canada

4. Department of Molecular Oncology British Columbia Cancer Agency Vancouver BC Canada

5. Department of Laboratory Medicine and Pathology Lions Gate Hospital North Vancouver BC Canada

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14026

Reference31 articles.

1. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

2. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

3. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

4. Genetic instability of microsatellites in endometrial carcinoma;Risinger JI;Cancer Res.,1993

5. A practical guide to biomarkers for the evaluation of colorectal cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer;Journal of Cancer Research and Clinical Oncology;2023-06-28

2. Patterns of DNA mismatch repair protein expression for primary and recurrent colorectal cancer at an advanced surgical unit: A retrospective audit;Colorectal Disease;2022-11-21

3. Dostarlimab for the treatment of advanced endometrial cancer;Expert Review of Clinical Pharmacology;2022-01-02

4. Clinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy;Japanese Journal of Clinical Oncology;2021-11-09

5. Breast and Gynecologic Tumors;Practical Oncologic Molecular Pathology;2021